Information Provided By:
Fly News Breaks for January 9, 2019
LJPC
Jan 9, 2019 | 07:18 EDT
H.C. Wainwright analyst Edward White lowered his price target for La Jolla Pharmaceutical to $25 saying Giapreza guidance fell short of his expectations. The analyst, however, keeps a Buy rating on the shares.
News For LJPC From the Last 2 Days
There are no results for your query LJPC